ChartRow logo
NHI
$66.35+2.55%
as of close, Oct 20, 2026
☾ AH $66.35 +2.55%
PeersOHIDOCAHRVTRSPYQQQ
Share this page

NHI financial statements

The full income statement, balance sheet, and cash-flow statement for National Health Investors Inc. (NHI), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 43.4M2024-09 45.4M2024-12 45.7M2025-03 46.7M2025-06 47.5M2025-09 47.6M2025-12 48.4M2026-03 48.5M2026-06 49.1M+13.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue376M+12.1%335M+4.8%320M+15.0%278M-6.9%299M-10.2%
239M+12.8%212M+5.5%201M-16.9%242M+11.9%216M+33.6%
Selling, general & administrative26.9M+29.6%20.7M+7.4%19.3M-15.2%22.8M+23.5%18.4M+38.5%
General & administrative26.9M+29.6%20.7M+7.4%19.3M-15.2%22.8M+23.5%18.4M+38.5%
Interest expense57.4M-4.2%59.9M+3.0%58.2M+29.5%44.9M-11.6%50.8M-3.9%
Interest & investment income———24.7M-10.7%27.7M+8.1%
Net interest income——269M+11.9%240M—
Equity-method income3.66M+811.4%402K-27.6%555K-2.5%569K+136.8%-1.54M+50.6%
142M+3.0%138M+1.7%136M+104.3%66.4M-40.6%112M-39.6%
Net income to non-controlling interest-1.39M-3.3%-1.35M-5.7%-1.27M-41.1%-902K-653.4%163K-11.9%
Net income to common142M+3.0%138M+1.7%136M+104.2%66.4M-40.6%112M
$3.02-3.5%$3.13+0.0%$3.13+111.5%$1.48-39.3%$2.44-41.1%
EPS (basic)$3.03-3.5%$3.14+0.3%$3.13+111.5%$1.48-39.6%$2.45-40.8%
Weighted-avg shares (basic)46.9M+6.9%43.8M+1.1%43.4M-3.1%44.8M-2.1%45.7M+2.3%
Weighted-avg shares (diluted)47.1M+6.7%44.1M+1.6%43.4M-3.1%44.8M-2.0%45.7M+2.3%
Dividends per share$3.64+1.1%$3.60+0.0%$3.60+0.0%$3.60-5.3%$3.80-13.8%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Cash & equivalents19.6M-19.2%24.3M+8.7%22.3M+15.8%19.3M-48.4%37.4M-13.7%
Accounts receivable———3.62M+12.8%3.21M+23.7%
2.80B+7.0%2.61B+5.1%2.49B-0.8%2.51B-11.7%2.84B-9.0%
Property, plant & equipment2.47B+11.8%2.21B+4.9%2.11B-0.5%2.12B-8.6%2.32B-13.1%
Operating lease right-of-use1.49M-0.9%1.50M-4.0%1.56M-2.3%1.60M—
1.26B+2.3%1.23B+1.2%1.21B-0.3%1.22B-7.9%1.32B-17.3%
Operating lease liability (total)1.66M-2.1%1.70M-0.3%1.71M-1.1%1.72M—
Deferred tax liabilities
0.00————
1.52B+11.3%1.37B+9.0%1.25B-1.3%1.27B-15.7%1.51B-0.3%
Common stock483K+5.7%457K+5.3%434K+0.0%434K-5.4%459K+1.5%
Additional paid-in capital1.92B+10.7%1.74B+8.3%1.60B+0.3%1.60B+0.5%1.59B+3.3%
Retained earnings2.75B+5.5%2.60B+5.6%2.47B+5.8%2.33B—
Accumulated other comprehensive income
————0.00+100.0%
Non-controlling interest8.17M-8.4%8.91M-14.6%10.4M+5.9%9.86M-0.4%9.90M-7.6%
Total equity incl. non-controlling1.53B+11.2%1.38B+8.8%1.26B-1.2%1.28B-15.6%1.52B-0.4%
Total liabilities & equity2.80B+7.0%2.61B+5.1%2.49B-0.8%2.51B-11.7%2.84B-9.0%
Common shares issued49.1M+7.5%45.7M+5.2%43.4M+0.0%43.4M-5.4%45.9M+1.5%
Common shares outstanding48.3M+5.7%45.7M+5.2%43.4M+0.0%43.4M-5.4%45.9M+1.5%
Shares outstanding (cover)48.4M+5.9%45.7M+5.2%43.4M+0.0%43.4M-5.4%45.9M+1.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
237M+13.9%208M+12.6%184M-0.5%185M-12.1%211M-9.2%
Depreciation & amortization80.9M+13.3%71.4M+2.1%70.0M-1.3%70.9M-12.3%80.8M-2.8%
Share-based compensation
————5.08M-6.7%
-269M-40.0%-192M-1553.6%-11.6M-105.9%198M+6.8%185M+306.5%
Capital expenditure294M+86.2%158M+218.7%49.6M+350.8%11.0M-78.2%50.3M-56.9%
Free cash flow-57.5M-215.3%49.8M-63.1%135M-22.6%174M+8.6%161M+39.1%
Acquisitions0.000.000.000.000.00
25.7M+289.5%-13.6M+92.0%-170M+57.7%-401M+0.4%-403M-260.6%
Long-term debt issued346M0.000.000.00-100.0%397M
Long-term debt repaid201M+166.2%75.4M-81.8%415M+206.8%135M-53.8%293M+570.8%
Common stock issued182M+27.5%142M0.000.00-100.0%47.9M+38.3%
Common stock repurchased0.000.000.00-100.0%152M0.00
Dividends paid170M+8.4%157M+0.2%156M-3.4%162M-11.6%183M-6.0%
Net change in cash-6.88M-464.9%1.89M-39.2%3.10M+117.3%-18.0M-162.0%-6.86M-122.4%
Interest paid51.5M-7.0%55.4M+6.7%51.9M+21.7%42.7M-2.3%43.7M+0.6%
Income taxes paid200K+0.0%200K+0.0%200K+0.0%200K+100.0%100K-28.6%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap3.70B+16.7%3.17B+30.6%2.42B+7.0%2.27B-14.0%2.64B-15.7%
P/E26.0×+13.3%22.9×-0.2%23.0×-28.0%31.9×+35.4%23.6×+39.6%
P/S9.8×+4.2%9.4×+21.2%7.8×-4.6%8.2×-7.3%8.8×-6.1%
P/B2.4×+4.8%2.3×+20.4%1.9×+10.9%1.7×-0.8%1.7×-15.4%
P/FCF—63.5×+356.9%13.9×-1.5%14.1×-14.0%16.4×-39.4%
Earnings yield3.8%-11.7%4.4%+0.2%4.4%+38.8%3.1%-26.1%4.2%-28.4%
FCF yield—1.6%-78.1%7.2%+1.5%7.1%+16.3%6.1%+64.9%
Dividend yield4.8%-8.2%5.2%-19.4%6.4%-6.5%6.9%+4.2%6.6%+3.8%
Source filing10-K10-K10-K10-K10-K

About this data

Source: NHI’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all NHI filings on SEC EDGAR → Not investment advice.